Jump Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,266
Closed -$1.23M 2043
2026
Q1
$1.23M Buy
20,266
+10,948
+117% +$638K 0.02% 841
2025
Q4
$503K Sell
9,318
-205,585
-96% -$9.89M 0.01% 1314
2025
Q3
$9.69M Buy
+214,903
New +$10M 0.12% 225
2025
Q2
Sell
-7,188
Closed -$438K 1814
2025
Q1
$438K Buy
+7,188
New +$419K 0.01% 1131
2024
Q4
Sell
-4,500
Closed -$233K 1661
2024
Q3
$233K Sell
4,500
-443,771
-99% -$20.8M ﹤0.01% 1410
2024
Q2
$18.6M Buy
448,271
+420,110
+1,492% +$18.8M 0.37% 26
2024
Q1
$1.53M Sell
28,161
-145,584
-84% -$7.42M 0.04% 577
2023
Q4
$8.91M Buy
173,745
+154,886
+821% +$8.13M 0.28% 42
2023
Q3
$1.09M Sell
18,859
-21,647
-53% -$1.33M 0.04% 626
2023
Q2
$2.59M Buy
+40,506
New +$2.72M 0.1% 288
2022
Q3
Sell
-4,451
Closed -$343K 1604
2022
Q2
$343K Buy
+4,451
New +$339K 0.01% 1010
2022
Q1
Sell
-4,643
Closed -$290K 1561
2021
Q4
$290K Sell
4,643
-9,132
-66% -$536K 0.02% 909
2021
Q3
$816K Buy
13,775
+6,203
+82% +$409K 0.06% 343
2021
Q2
$506K Sell
7,572
-37,134
-83% -$2.42M 0.05% 471
2021
Q1
$2.82M Buy
+44,706
New +$2.78M 0.26% 45
2020
Q4
Sell
-15,033
Closed -$907K 955
2020
Q3
$907K Buy
+15,033
New +$905K 0.18% 153

Other funds holding BMY

Jump Financial's BMY Position: Q2 2026 in Review

Jump Financial sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 20,266 shares — an estimated $1.23M sold.

Jump Financial first reported a position in BMY in Q3 2020 and held it in 16 quarters. The position peaked at $18.6M in Q2 2024. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Jump Financial reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 20,266 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.23M.
  • Jump Financial first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 16 quarters.
  • Jump Financial's Bristol-Myers Squibb position peaked at $18.6M in Q2 2024.
  • 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.